Akari Therapeutics (AKTX) Other Non-Current Assets (2015 - 2026)
Akari Therapeutics (AKTX) posted quarterly Other Non-Current Assets of $60000.0 for Q1 2026, little changed year-on-year from $60000.0 in Q1 2025, and little changed on a QoQ basis from $60000.0 in Q4 2025.
Akari Therapeutics (AKTX) Other Non-Current Assets (2015 - 2026) Analysis & Trends
Akari Therapeutics (AKTX) has reported Other Non-Current Assets for 8 consecutive years, with $60000.0 the latest figure, recorded in Q1 2026.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $60000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $60000.0, changed 0.0% from the prior year.
- Other Non-Current Assets held at $60000.0 in Q1 2026 per AKTX's latest filing, from $60000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for AKTX reached as high as $60000.0 in Q4 2024 and fell as low as $60000.0 in Q4 2024.
- A 3-year average of $60000.0 and a median of $60000.0 in 2024 frame the typical range for Other Non-Current Assets.
- The largest YoY upside for Other Non-Current Assets was 0.0% in 2025 against a maximum downside of 0.0% in 2025.
- Year by year, Other Non-Current Assets stood at $60000.0 in 2024, then changed by 0.0% to $60000.0 in 2025, then changed by 0.0% to $60000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $60000.0, $60000.0, and $60000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Akari Therapeutics | 86.55 Mn | 86.55 Mn | - | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 60,000.00 |
| Jun 30, 2019 | 17,364.00 |
| Mar 31, 2019 | 147,924.00 |
| Dec 31, 2018 | 521,829.00 |
| Jun 30, 2018 | 521,408.00 |
| Dec 31, 2017 | 142,235.00 |
| Jun 30, 2017 | 142,200.00 |
| Dec 31, 2016 | 142,168.00 |
| Jun 30, 2016 | 142,114.00 |
| Mar 31, 2016 | 142,079.00 |
| Dec 31, 2015 | 142,079.00 |
| Sep 30, 2015 | 142,079.00 |